Hepatitis C and Diabetes: The Connection, and Why a Single Blood Test Matters

Two facts sit next to each other and are almost never discussed together. Pakistan has more people living with hepatitis C than any other country in the world — around 9 million, according to WHO figures reported in 2024 (opens in a new tab). And hepatitis C, more than most infections, interferes directly with how the body handles insulin.

If you are managing diabetes here, that overlap is worth knowing about. Not because you should assume you have hepatitis C — most people don't — but because the test is simple, the treatment now cures almost everyone, and the virus is quiet enough that people carry it for decades without a single symptom.

The link is real, and it runs in both directions

Chronic hepatitis C is not just a liver infection. It changes how insulin works. Research reviewed in the National Library of Medicine (opens in a new tab) found that in the large NHANES III population study, people aged 40 or older who tested positive for hepatitis C antibodies had an odds ratio of 3.77 for type 2 diabetes. In one prospective study of high-risk individuals, those with HCV infection were more than eleven times as likely to go on to develop type 2 diabetes as those without it.

The most telling comparison is with hepatitis B. In matched groups of patients, insulin resistance appeared in about 5% of chronic hepatitis B cases but 35% of chronic hepatitis C cases. Liver damage alone doesn't explain that gap — something about this particular virus does. Researchers have traced it to the virus interfering with insulin signalling inside liver cells, alongside inflammatory pathways like TNF-alpha and cellular stress responses.

The traffic goes the other way too. Insulin resistance and type 2 diabetes speed up the scarring of the liver in someone who already has chronic hepatitis C. So a person carrying both is in a loop where each condition makes the other harder.

What curing it does to blood sugar

This is the part that makes testing worth the trouble. A systematic review and meta-analysis (opens in a new tab) pooling four cohort studies and 2,648 participants found that among people with type 2 diabetes who cleared the virus with modern antivirals, HbA1c fell by an average of 0.50 percentage points — a drop comparable to what many people work hard for with diet and medication changes.

The authors are careful, and so are we: these studies had no control groups, so the improvement can't be credited to the antivirals alone. But the direction is consistent across studies, and it fits what we know about the mechanism. Clearing the infection removes something that was actively working against your glucose control.

Why so many people never find out

Hepatitis C is famous for being silent. The World Health Organization (opens in a new tab) notes that many infections cause no symptoms at all for years. When symptoms do surface — fatigue, loss of appetite, nausea, abdominal pain, dark urine, yellowing of the eyes or skin — they arrive late, and several of them are easy to blame on something else. Fatigue in particular is something almost everyone managing diabetes has felt for entirely unrelated reasons.

That is exactly why the recommendation is to test rather than to wait for a reason to test. The CDC advises every adult aged 18 and over (opens in a new tab) to be screened at least once in their lifetime, and every pregnant woman during each pregnancy. WHO recommends general-population testing anywhere seroprevalence is above 2% — a threshold Pakistan clears comfortably.

The one risk that belongs specifically to diabetes

Hepatitis C spreads through blood. In Pakistan the main historical drivers have been unsafe injections and unscreened transfusions, along with shared razors at barbers and unsterilised dental and surgical instruments. But there is one route that concerns people with diabetes directly, and it is almost never mentioned in a clinic: shared fingerstick equipment.

A published case report (opens in a new tab) describes a 25-year-old medical student who pricked his own finger on the lancet of the glucose meter he was using to test his father — a man with diabetes and active hepatitis C. Three months later the son had acute hepatitis C of the same genotype, with no other risk factor anywhere in his history. One accidental prick, one shared lancing device.

It is not a one-off curiosity. CDC investigators (opens in a new tab) documented 15 hepatitis B outbreaks in long-term care facilities linked to assisted blood glucose monitoring between 2008 and 2019, including a case traced by genetic sequencing to two shared glucometers. Blood residue on a meter body is often invisible.

What the test actually involves

Testing happens in two steps, and knowing this in advance saves a lot of anxiety. The first is an anti-HCV antibody test — a routine blood draw, widely available and inexpensive. A reactive result does not mean you currently have hepatitis C. Antibodies persist after an infection has cleared, whether on its own or after treatment.

The second step, done only if the antibody test is reactive, is an HCV RNA test (often called HCV PCR). This looks for the virus itself, and it is the one that tells you whether the infection is active. Confirming that distinction before anyone starts talking about treatment is standard practice, not extra caution.

If it is positive

The honest headline here is a good one. Hepatitis C treatment used to mean interferon injections, months of feeling terrible, and no guarantee of success. That era is over. Direct-acting antivirals are tablets, taken for 12 to 24 weeks depending on whether the liver is scarred, and WHO states they cure more than 95% (opens in a new tab) of people who take them.

Pakistan has committed roughly $250 million to eliminating hepatitis C by 2030 under the Prime Minister's programme, with free screening, diagnosis and treatment, and a stated target of treating half of everyone infected by 2027. Coverage is being rolled out district by district, so what is available near you depends on where you live — but free is the intended default, not the exception.

Two practical notes if you do start treatment. Tell the prescribing doctor every medicine you take, diabetes ones included, so interactions can be checked before you begin. And keep logging your readings through the treatment course: if your glucose control improves as the infection clears, that shows up in your numbers first, and your doctor may want to revisit your doses because of it.

Your readings tell the longer story

Patterns that build over months — a slow drift upward, or an unexplained improvement — are the ones that are easiest to miss and most useful to a doctor. Logging your sugars in Diatic gives you something concrete to show at your next appointment, whatever else is going on.

Start logging with Diatic (opens Diatic on Google Play in a new tab)